These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4007418)

  • 41. Serum copper and ceruloplasmin levels and urinary copper excretion in thermal injury.
    Boosalis MG; McCall JT; Solem LD; Ahrenholz DH; McClain CJ
    Am J Clin Nutr; 1986 Dec; 44(6):899-906. PubMed ID: 3788837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin.
    Chowrimootoo GF; Ahmed HA; Seymour CA
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):851-5. PubMed ID: 8645167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Wilson's disease. A histological review of 7 patients and the value of histological copper positivity in relation to other hepatopathies].
    Blasco A; Domínguez P; Colina F; Castellano G
    Med Clin (Barc); 1992 Feb; 98(6):207-11. PubMed ID: 1373211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Importance of liver puncture biopsy and endoscopic retrograde cholangiography in patients with chronic anicteric unexplained cholestasis. A retrospective study in 79 patients].
    Sapey T; Turlin B; Canva-Delcambre V; Mendler MH; Deugnier Y; Brissot P; Guyader D
    Gastroenterol Clin Biol; 1999 Feb; 23(2):178-85. PubMed ID: 10353011
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of copper-loading disease in Bedlington terriers and Wilson's disease in humans.
    Su LC; Ravanshad S; Owen CA; McCall JT; Zollman PE; Hardy RM
    Am J Physiol; 1982 Sep; 243(3):G226-30. PubMed ID: 7114265
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Concentrations of copper and zinc in liver and serum samples in biliary atresia patients at different stages of traditional surgeries.
    Sato C; Koyama H; Satoh H; Hayashi Y; Chiba T; Ohi R
    Tohoku J Exp Med; 2005 Dec; 207(4):271-7. PubMed ID: 16272797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
    Marecek Z; Heyrovský A; Volek V
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new neurological entity manifesting as involuntary movements and dysarthria with possible abnormal copper metabolism.
    Tagawa A; Ono S; Shibata M; Imai T; Suzuki M; Shimizu N
    J Neurol Neurosurg Psychiatry; 2001 Dec; 71(6):780-3. PubMed ID: 11723201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Asymptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid.
    Hayashi H; Higuchi T; Ichimiya H; Hishida N; Sakamoto N
    Gastroenterology; 1990 Aug; 99(2):533-5. PubMed ID: 2365199
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Defective biliary excretion of copper in Wilson's disease.
    Frommer DJ
    Gut; 1974 Feb; 15(2):125-9. PubMed ID: 4820637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urinary 24-hour copper excretion at the time of diagnosis in children with Wilson's disease.
    Aksu AÜ; Sarı S; Gürkan ÖE; Dalgıç B
    Acta Gastroenterol Belg; 2018; 81(3):410-414. PubMed ID: 30350530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatic Dry Copper Weight in Pediatric Autoimmune Liver Disease.
    Nayagam JS; Joshi D; Thompson RJ; Dhawan A; Hadzic N; Mestre-Alagarda C; Deheragoda M; Samyn M
    J Pediatr Gastroenterol Nutr; 2023 Feb; 76(2):e21-e26. PubMed ID: 36332083
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Wilson's disease.
    Loudianos G; Gitlin JD
    Semin Liver Dis; 2000; 20(3):353-64. PubMed ID: 11076401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic failure after injury - a common pathogenesis with sclerosing cholangitis?
    Zilkens C; Friese J; Köller M; Muhr G; Schinkel C
    Eur J Med Res; 2008 Jul; 13(7):309-13. PubMed ID: 18700186
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 99mTc-mebrofenin scintigraphy for evaluating liver disease in a rat model of Wilson's disease.
    Malhi H; Bhargava KK; Afriyie MO; Volenberg I; Schilsky ML; Palestro CJ; Gupta S
    J Nucl Med; 2002 Feb; 43(2):246-52. PubMed ID: 11850492
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early cell transplantation in LEC rats modeling Wilson's disease eliminates hepatic copper with reversal of liver disease.
    Malhi H; Irani AN; Volenberg I; Schilsky ML; Gupta S
    Gastroenterology; 2002 Feb; 122(2):438-47. PubMed ID: 11832458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study.
    Merle U; Schaefer M; Ferenci P; Stremmel W
    Gut; 2007 Jan; 56(1):115-20. PubMed ID: 16709660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnosis of sclerosing cholangitis with technetium 99m-labeled iminodiacetic acid planar and single photon emission computed tomographic scintigraphy.
    Rodman CA; Keeffe EB; Lieberman DA; Krishnamurthy S; Krishnamurthy GT; Gilbert S; Eklem MJ
    Gastroenterology; 1987 Mar; 92(3):777-85. PubMed ID: 3493188
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatic manifestations of Wilson's disease: 12-year experience in a Swiss tertiary referral centre.
    Vieira Barbosa J; Fraga M; Saldarriaga J; Hiroz P; Giostra E; Sempoux C; Ferenci P; Moradpour D
    Swiss Med Wkly; 2018 Dec; 148():w14699. PubMed ID: 30576569
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinicopathologic features of the syndrome of primary sclerosing cholangitis.
    Wiesner RH; LaRusso NF
    Gastroenterology; 1980 Aug; 79(2):200-6. PubMed ID: 7399227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.